Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123488334 | 12348833 | 4 | F | 2003 | 20160707 | 20160509 | 20160708 | PER | US-PFIZER INC-2016245965 | PFIZER | 67.00 | YR | F | Y | 61.00000 | KG | 20160708 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123488334 | 12348833 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, 2X/DAY, CAPSULE | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | BID | |||||||
| 123488334 | 12348833 | 2 | C | BUPROPION HYDROCHLORIDE XL | BUPROPION HYDROCHLORIDE | 1 | 10 MG, DAILY | 0 | 10 | MG | PROLONGED-RELEASE TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123488334 | 12348833 | 1 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123488334 | 12348833 | Drug ineffective | |
| 123488334 | 12348833 | Fatigue | |
| 123488334 | 12348833 | Irritability | |
| 123488334 | 12348833 | Mood swings | |
| 123488334 | 12348833 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123488334 | 12348833 | 1 | 200305 | 0 | ||
| 123488334 | 12348833 | 2 | 200308 | 0 |